Morningstar

Eli Lilly and Co LLY

Morningstar Rating
Unlock
Stock XNYS Rating as of
$891.07 +6.59 (0.75%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
LLY is trading at a 418% premium.
Price
$891.07
Fair Value
$688.00
Uncertainty
High
1-Star Price
$549.00
5-Star Price
$741.00
Economic Moat
Wjmdt
Capital Allocation
Yvkprdkyzx

Bulls Say, Bears Say

Bulls

Lilly's strong leadership in weight-loss drugs should drive industry-leading growth with approved drugs and well-positioned next-generation weight-loss drugs in the pipeline.

Bears

The risks to success for Alzheimer’s drug Kisunla remain high because of bottlenecks in patient diagnosis, required scans and monitoring, as well as competition.

Show More

News

View All

Trading Information

Previous Close Price
$884.48
Day Range
$878.70–893.35
52-Week Range
$516.57–972.53
Bid/Ask
$890.00 / $891.00
Market Cap
$802.34 Bil
Volume/Avg
1.8 Mil / 3.3 Mil

Key Statistics

Price/Earnings (Normalized)
79.84
Price/Sales
20.69
Dividend Yield (Trailing)
0.56%
Dividend Yield (Forward)
0.58%
Total Yield
0.56%

Company Profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Growth
Total Number of Employees
43,000
Website
https://www.lilly.com

Competitors

Valuation

View More
Metric
LLY
MRK
BMY
Price/Earnings (Normalized)
 79.8417.227.02
Price/Book Value
 59.166.526.40
Price/Sales
 20.694.572.35
Price/Cash Flow
 80.2215.237.21
Price/Earnings
LLY
MRK
BMY

Financial Strength

Metric
LLY
MRK
BMY
Quick Ratio
 0.610.880.94
Current Ratio
 1.111.471.16
Interest Coverage
 15.0813.07−3.16
Quick Ratio
LLY
MRK
BMY

Profitability

Metric
LLY
MRK
BMY
Return on Assets (Normalized)
 13.15%15.46%3.04%
Return on Equity (Normalized)
 69.16%41.15%11.63%
Return on Invested Capital (Normalized)
 23.97%22.92%5.77%
Return on Assets
LLY
MRK
BMY

Drug Manufacturers - General Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Johnson & Johnson
JNJ
KtttfsyTbzt$388.0 Bil
 AbbVie Inc
ABBV
XkzlycnbSrpl$347.7 Bil
 Merck & Co Inc
MRK
FwhrxrjtTfm$284.1 Bil
 Roche Holding AG ADR
RHHBY
GtkrhjczSlg$252.2 Bil
 AstraZeneca PLC ADR
AZN
PdwlrxgqzXcxb$244.7 Bil
 Novartis AG ADR
NVS
ZtvltzbnPxp$232.6 Bil
 Amgen Inc
AMGN
McmncjyzbbKrc$171.8 Bil
 Pfizer Inc
PFE
ZvspzdfYtgs$162.1 Bil
 Sanofi SA ADR
SNY
HygsstjqJkp$145.1 Bil

Sponsor Center